Posted: Sun., Jul. 2, 2006, 10:47pm PT

Solid start for 'Cars' in Japan bow

Toon is safely into gear, but lags Pixar's race leaders

TOKYO – Pixar's "Cars" drove off smoothly, but did not exactly burn rubber in Japan, its first major Asian playdate.

Opening on Saturday, "Cars" grossed a solid but unspectacular Y379 million ($3.33 million) on 347,000 admissions on its first weekend in Japan, where it opened on 644 screens.

That's a few lengths behind "The Incredibles," which completed its opening weekend lap with $6.57 million from 689 screens, and off the pace compared with race leader "Finding Nemo," which drove off with $9.82 million from 720 screens.

Distrib Buena Vista is accordingly aiming for the $35 million B.O. mark when the pic finally passes the chequered flag. "Incredibles" finished with $46 million and "Nemo" $96 million -- the biggest Pixar hit in Japan.

Although the target aud is essentially the same as Pixar's pace-setters, Japanese fans know little or nothing about the NASCAR boom that helped fuel the pic’s B.O. in the US. "People here are more into Formula 1 racing," a Buena Vista spokesman said. The pic pulled in mainly kids and their families on its opening weekend, with 94% of the prints being sub-titled for the under-12 demo.


TALKBACK:

Have an opinion about this article? Be the first to comment




Q What are the top 3 things affecting our industry today?
A. Moisaque - I believe its has to do with Ideas because you will need that, second is money because mon... more >


Submit this form
Tressa, one of the many stars of A&E's 'Intervention,' talks about her lengthy battle with methamphetamine. ; reality show; intervention; A&E; emmy contenders; drug addicts; variety; Interviews with Erick McCormack, Daniel Dae Kim & Christa Miller, stars of A&E's new sci-fi thriller, 'The Andromeda Strain.'; Erick McCormack; A&E; tv; sci-fi; The Andromeda Strain; variety; Daniel Dae Kim & Christa Miller;


© 2008 Reed Business Information, a division of Reed Elsevier Inc. All rights reserved. Use of this website is subject to its Terms & Conditions of Use. View our Privacy Policy.